Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Biological pathways and mechanistic trials centered at new Long COVID conference in Amsterdam

Researchers, clinicians, and advocates gathered for the inaugural conference of the International Society for Long COVID and Post-Acute Infection Syndromes in the Netherlands in late August. The four-day event featured hundreds of presentations and posters about trials and disease mechanisms. The post Biological pathways and mechanistic trials centered at new Long COVID conference in Amsterdam…

Biological pathways and mechanistic trials centered at new Long COVID conference in Amsterdam

In late August, the inaugural conference for the International Society for Long COVID and Post-Acute Infection Syndromes took place in Amsterdam. The four-day event, hosted by the newly formed society, featured hundreds of presentations and posters on trials and disease mechanisms. The conference was held at the H’ART Museum, a prominent cultural and conference venue on the banks of the Amstel canal.

Researchers, clinicians, advocates, and others gathered to discuss the clinical trials that had produced disappointing results in Long COVID research. The focus shifted towards exploring the reasons behind these null findings and emphasizing the need for more carefully designed trials that target the underlying pathological mechanisms at play.

During the conference, the PROBE-PASC program, funded by the U.S. Department of Defense, was unveiled. This program aims to lead mechanistic trials for Long COVID, with the first trial testing the monoclonal antibody Pemgarda along with the immune-modulating drug hydroxychloroquine.

Written by urgent.news from The Sick Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at thesicktimes.org →

More in Health & Medicine

More from Tuesday 6 October →